Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Houtou Jianweiling is a traditional herbal medicine formulation, primarily derived from the *Hericium erinaceus* (Lion's Mane) mushroom, used for the treatment of various gastrointestinal disorders. It is specifically utilized for chronic non-atrophic gastritis due to its purported ability to promote the repair and regeneration of the gastric mucosa, exert anti-inflammatory effects, and provide cytoprotection against gastric acid and pepsin. The University of Karachi has sponsored clinical research to evaluate its efficacy and safety in a randomized, double-blind, non-inferiority trial comparing it to the proton pump inhibitor omeprazole. The active constituents, including polysaccharides and diterpenoids like erinacines, are thought to modulate inflammatory cytokines and enhance mucosal barrier function.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Houtou Jianweiling.